Health News

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), today announced that the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region of the People’s Republic of China has granted regulatory approval for ANKTIVA® (nogapendekin alfa inbakicept-pmln). The approval establishes ANKTIVA’s initial presence in Asia and reflects the Company’s strategy to expand global access through reliance-based regulatory pathways. In Macau, ANKTIVA is approved in co...

DENVER--(BUSINESS WIRE)--Cleerly, a leader in AI-based cardiovascular imaging analysis, presented findings from its multicenter INVICTUS registry at the recent European Congress of Radiology (ECR 2026) in Vienna, Austria. The presentation titled, “Artificial Intelligence-Based CCTA Quantification of Atherosclerosis Burden: Comparison With IVUS in the INVICTUS Registry” was presented by Rine Nakanishi, MD, PhD, during the Clinical Trials in Radiology: Spotlight Session on March 5, 2026. The anal...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Molina Healthcare of Michigan and The MolinaCares Accord Donate $135,000 to senior centers to pilot programs addressing social isolation....

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting...

MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma to Present 17 Scientific Abstracts at AAD 2026...

CORAL GABLES, Fla.--(BUSINESS WIRE)--Health Gorilla today released materials demonstrating that GuardDog always represented to Health Gorilla that its services were for treatment purposes. The materials in question are a 2025 case study that GuardDog developed with Health Gorilla which was meant to be released for marketing purposes for both companies. The case study reflects GuardDog’s continuing description over a period of years that its services were for treatment purposes, because it repre...

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Directors has agreed to nominate Parsa Kiai and Jeff Rose from Steamboat Capital Partners LLC as independent director candidates to stand for election at the company’s 2026 Annual Meeting of Stockholders, which is provisionally scheduled for May 19, 2026. These nominations are pursuant to a Cooperati...

CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com reported 2025 net sales of $49.0 million, a 46% increase over 2024, as partner services prescription revenues increased 87%....

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for levacetylleucine for the treatment of Ataxia-Telangiectasia (A-T), a rare, progressive, inherited neurodegenerative disorder. This submission represents the first regulatory application submitted to the U.S. Food and Drug Administration seeking approval of a therapy for the treatment of Ataxia-Telangiectasia. The sNDA seeks...

TORRANCE, Calif.--(BUSINESS WIRE)--A new global Alliance between Hamamatsu Photonics K.K and Sakura Finetek Global...